Johnson & Johnson

Johnson & Johnson as of June 30, 2024

Portfolio Holdings for Johnson & Johnson

Johnson & Johnson holds 20 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Protagonist Therapeutics (PTGX) 21.2 $85M 2.4M 34.65
Rapport Therapeutics (RAPP) 14.5 $58M 2.5M 23.26
CVRX (CVRX) 12.3 $49M 4.1M 11.99
Legend Biotech Corporation Sponsored Ads (LEGN) 9.0 $36M 815k 44.29
Contineum Therapeutics Cl A (CTNM) 8.7 $35M 2.0M 17.61
Nanobiotix Sponsored Ads (NBTX) 7.0 $28M 5.6M 5.00
Meiragtx Holdings (MGTX) 7.0 $28M 6.6M 4.21
Procept Biorobotics Corp (PRCT) 5.5 $22M 358k 61.09
Neumora Therapeutics (NMRA) 4.5 $18M 1.8M 9.83
Xencor (XNCR) 3.5 $14M 748k 18.93
Fate Therapeutics (FATE) 2.8 $11M 3.4M 3.28
Arrowhead Pharmaceuticals (ARWR) 1.6 $6.4M 248k 25.99
Rallybio Corp (RLYB) 1.2 $4.9M 3.6M 1.34
Nano-X Imaging Ord Shs (NNOX) 0.3 $1.2M 159k 7.34
Vor Biopharma (VOR) 0.3 $1.1M 1.1M 1.00
Aldeyra Therapeutics (ALDX) 0.2 $992k 300k 3.31
Chardan Healthcare Acqu- Ord (PHGE) 0.2 $646k 1.9M 0.34
D Fluidigm Corp Del (LAB) 0.1 $552k 312k 1.77
Adicet Bio (ACET) 0.1 $441k 365k 1.21
Senseonics Hldgs (SENS) 0.0 $22k 55k 0.40